DALBAR Launches Finance Lab Podcast
New Podcast Provides a Gateway to Practical Financial Insights from Real Experts MARLBOROUGH, Mass.–(BUSINESS WIRE)–DALBAR…
New Podcast Provides a Gateway to Practical Financial Insights from Real Experts MARLBOROUGH, Mass.–(BUSINESS WIRE)–DALBAR…
LOS ANGELES–(BUSINESS WIRE)–#AIforLaw–Amid the backdrop of 6,080 lateral associate moves within the Am Law 200…
Leading analyst firm GigaOm further lauds Torq for its “extensive feature set” and “impressive portfolio…
New CrowdStrike Marketplace delivers one-stop shop to reduce risk and cybersecurity stack complexity on the…
WICHITA, Kan.–(BUSINESS WIRE)–Textron Aviation today announced the company is adding 16,000 square feet to its…
Collaboration will advance how modern enterprise software is secured and maintained MONTREAL & MIAMI–(BUSINESS WIRE)–#ML4code—Mila…
New research explores the evolution of cyber risk reporting in light of SEC mandates and…
SVP, Chief Control and Quality Officer part of an expert panel of women leaders in…
LONDON, Sept. 18, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology…
LONDON, Sept. 18, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology…
NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
Prompted by advice from FDA regarding study design, 60P Australia Pty Ltd, a majority-owned subsidiary…
Prompted by advice from FDA regarding study design, 60P Australia Pty Ltd, a majority-owned subsidiary…
MONTREAL, Sept. 18, 2023 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH)…
MONTREAL, Sept. 18, 2023 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH)…
After more than 15 years serving on AnaptysBio’s Board of Directors, Jamie Topper, M.D., Ph.D.,…
After more than 15 years serving on AnaptysBio’s Board of Directors, Jamie Topper, M.D., Ph.D.,…
Promising exarafenib combination data in NRAS mutant melanoma; intend to select two doses in the…
Promising exarafenib combination data in NRAS mutant melanoma; intend to select two doses in the…